Helix Biopharma (HBPCF) News Today $0.60 0.00 (0.00%) As of 08/22/2025 Add Compare Share Share Headlines Stock AnalysisChartEarningsHeadlinesBuy This Stock HBPCF Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Helix BioPharma Files Interim Financial Statements for April 2025June 16, 2025 | tipranks.comHelix BioPharma Appoints New CFO to Drive Strategic GrowthJune 2, 2025 | tipranks.comHelix BioPharma Secures $13 Million Financing to Advance Cancer TherapiesMay 14, 2025 | tipranks.comHelix BioPharma Appoints New CEO to Propel Clinical AdvancementsApril 10, 2025 | tipranks.comHelix BioPharma Engages ITG for Market-Making ServicesApril 3, 2025 | tipranks.comHelix BioPharma Corp. Announces Key Decisions from Annual MeetingMarch 26, 2025 | tipranks.comHelix BioPharma Releases Interim Financial Statements for January 2025March 18, 2025 | tipranks.comHelix BioPharma to Present Promising Cancer Treatment Findings at EMIM 2025March 11, 2025 | tipranks.comHelix BioPharma Enhances Leadership with Oncology ExpertsMarch 11, 2025 | tipranks.comHelix BioPharma Extends Meeting for Key ApprovalsMarch 3, 2025 | tipranks.comHelix BioPharma Secures $3 Million Through Private PlacementJanuary 9, 2025 | tipranks.comHelix BioPharma Appoints New CFODecember 11, 2024 | tipranks.comHelix BioPharma Expands Portfolio with Key AcquisitionNovember 29, 2024 | tipranks.comHelix BioPharma Secures U.S. Patent for Cancer TherapyNovember 21, 2024 | markets.businessinsider.comHelix BioPharma Highlights L-DOS47 at World ADCNovember 12, 2024 | markets.businessinsider.comHelix BioPharma (OTCMKTS:HBPCF) Stock Price Down 11.6% - Time to Sell?October 29, 2024 | marketbeat.comHelix Sunset Luxe Mattress Review 2023: The Best Helix Bed for Side SleepingSeptember 13, 2024 | cnet.comHelix BioPharma Corp HBPCDSeptember 5, 2024 | morningstar.comMHelix Dusk Luxe Mattress Review 2024: A Comfortable Pillow-Top BedApril 17, 2024 | cnet.comHelix BioPharma Corp. Reports Voting ResultsJanuary 22, 2024 | finance.yahoo.comHelix BioPharma Corp. Announces Fiscal 2024 First Quarter ResultsDecember 14, 2023 | finance.yahoo.comHelix BioPharma Corp HBPNovember 28, 2023 | morningstar.comMHelix Biopharma GAAP EPS of -C$0.03October 27, 2023 | msn.comHelix BioPharma Corp. Announces Fiscal 2023 Year-End ResultsOctober 27, 2023 | finance.yahoo.comHelix BioPharma Corp. (HBP)September 14, 2023 | uk.investing.comHELIX BIOPHARMA CORP (HBPCF) stock forecast and price targetJune 29, 2023 | finance.yahoo.comHelix Energy Up on BP Spill ContractMay 14, 2023 | thestreet.comHelix Biopharma Corp. Announces Fiscal 2023 Second Quarter ResultsMarch 15, 2023 | finance.yahoo.comIs Helix BioPharma (TSE:HBP) In A Good Position To Deliver On Growth Plans?January 31, 2023 | finance.yahoo.comHelix BioPharma appoints R&D headSeptember 3, 2022 | seekingalpha.comProactive news headlines including Shell, Maverix Metals, Helix BioPharma, Wellteq Digital Health and Trees CorpSeptember 2, 2022 | benzinga.comHelix Biopharma Corp. Announces Appointment of New Chief Financial OfficerMay 18, 2022 | finance.yahoo.comHelix BioPharma appoints Artur Gabor as its new CEO; adds three new board membersApril 18, 2022 | ca.proactiveinvestors.comHelix Biopharma Corp. Announces Extension of Early Warrant Exercise Incentive Program and Receipt of Private Placement SubscriptionApril 13, 2022 | finance.yahoo.comHelix Biopharma Corp. Announces Extension of Early Warrant Exercise Incentive Program and Receipt of Private Placement SubscriptionApril 13, 2022 | finance.yahoo.comHelix Biopharma GAAP EPS of -$0.01March 18, 2022 | seekingalpha.comHelix Biopharma Corp. Announces Unexpected Passing of Interim CEO and Chairman of the BoardMarch 16, 2022 | finance.yahoo.comHelix Biopharma Corp. (HBPCF)January 28, 2022 | nasdaq.comHelix BioPharma Corp. Reports Voting Results and Appointment of New Board DirectorJanuary 28, 2022 | finance.yahoo.comHelix Biopharma Corp. Announces Fiscal 2021 Year-End ResultsDecember 9, 2021 | finance.yahoo.comHelix BioPharma Corp. Provides Third Bi-Weekly MCTO Status UpdateNovember 30, 2021 | finance.yahoo.comHelix BioPharma Corp. Announces Delay of Annual FilingsOctober 15, 2021 | finance.yahoo.comHelix BioPharma Corp. Announces Delay of Annual FilingsOctober 15, 2021 | finance.yahoo.com Get Helix Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for HBPCF and its competitors with MarketBeat's FREE daily newsletter. Email Address HBPCF Media Mentions By Week HBPCF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HBPCF News Sentiment▼0.000.69▲Average Medical News Sentiment HBPCF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HBPCF Articles This Week▼00▲HBPCF Articles Average Week Get Helix Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for HBPCF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies SELLAS Life Sciences Group News Today Tevogen Bio News Today Actuate Therapeutics News Today Sangamo Therapeutics News Today Caribou Biosciences News Today Cellectis News Today Nkarta News Today Nuvectis Pharma News Today BioHarvest Sciences News Today Greenwich LifeSciences News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:HBPCF) was last updated on 8/24/2025 by MarketBeat.com Staff From Our PartnersNations are at war over what’s in this boxA resource known as Element 29 is quickly becoming one of the most sought-after materials on the planet. Goldm...Behind the Markets | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.On a quiet Friday afternoon, one trader spotted an overlooked stock. He bought shares. He shut down his ...Timothy Sykes | SponsoredOne tiny company just cracked Google’s $19B problemFor decades, this “AI metal” was trapped in labs, too slow and expensive to ever reach mass production. The...True Market Insiders | SponsoredElon Musk’s New TechnologyElon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...Paradigm Press | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Helix Biopharma Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Helix Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access